[Efficacy Of Vinpotropile In The Therapy Of Initial Signs Of Cerebrovascular Pathology]
Notes for this study:
||1.9 points (MMSE)
|Number of Subjects
Used vinpotropile (Pyracetam) as oral dose for 30 days in patients aged 50-78 with beginning stages of chronic brain ischemia. The rate of cognitive decline appears to be attenuated as assessed by the MMSE rating scale, and subjective well being increased.